Article
Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome.
Rheumatology (Oxford, England) - 1 Feb 2021
Thorlacius Guðný Ella, Hultin-Rosenberg Lina, Sandling Johanna K, Bianchi Matteo, Imgenberg-Kreuz Juliana, Pucholt Pascal, Theander Elke, Kvarnström Marika, Forsblad-d'Elia Helena, Bucher Sara Magnusson, Norheim Katrine B, Johnsen Svein Joar Auglænd, Hammenfors Daniel, Skarstein Kathrine, Jonsson Malin V, Baecklund Eva, Aqrawi Lara A, Jensen Janicke Liaaen, Palm Øyvind, Morris Andrew P, Meadows Jennifer R S, Rantapää-Dahlqvist Solbritt, Mandl Thomas, Eriksson Per, Lind Lars, Omdal Roald, Jonsson Roland, Lindblad-Toh Kerstin, Rönnblom Lars, Wahren-Herlenius Marie, Nordmark Gunnel
Abstract excerpt
OBJECTIVES: Clinical presentation of primary Sjögren's syndrome (pSS) varies considerably. A shortage of evidence-based objective markers hinders efficient drug development and most clinical trials have failed to reach primary endpoints. METHODS: We performed a multicentre study to identify patient subgroups based on clinical, immunological and genetic features. Targeted DNA sequencing of 1853 autoimmune-related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
